Schreiner MediPharm’s newly developed Booklet-Label with diverse security features is especially relevant considering pending regulations such as EU 2016/161 Falsified Medicine Directive which, upon enactment in February 2019, will require innovative and reliable solutions to protect patients against falsified medicines.

The Security Booklet-Label’s bottom layer contains a tab serving as a closure seal for tampering protection. When the seal is opened, a void effect emerges as an irreversible first-opening indication.

Applied to a medicine carton, the Booklet-Label allows a pharmacist, for example, to view the product information without opening the package or destroying the tamper protection. In addition, the label is equipped with three digital security features: The BitSecure copy detection pattern, the KeySecure tracing system as well as an integrated NFC chip for smart authentication.